PEDRON, Serena
 Distribuzione geografica
Continente #
NA - Nord America 2.310
EU - Europa 1.992
AS - Asia 1.482
SA - Sud America 172
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 5.989
Nazione #
US - Stati Uniti d'America 2.263
GB - Regno Unito 633
CN - Cina 566
SG - Singapore 507
IT - Italia 325
HK - Hong Kong 210
SE - Svezia 202
DE - Germania 183
BR - Brasile 146
IE - Irlanda 137
FR - Francia 131
FI - Finlandia 123
RU - Federazione Russa 117
KR - Corea 48
ES - Italia 33
VN - Vietnam 32
BE - Belgio 28
UA - Ucraina 27
CA - Canada 24
NL - Olanda 21
TR - Turchia 20
AR - Argentina 16
IN - India 16
JP - Giappone 14
MX - Messico 14
ID - Indonesia 12
IQ - Iraq 9
AT - Austria 7
TG - Togo 7
ZA - Sudafrica 7
BD - Bangladesh 5
IL - Israele 5
EC - Ecuador 4
EG - Egitto 4
IR - Iran 4
KG - Kirghizistan 4
PH - Filippine 4
PK - Pakistan 4
AL - Albania 3
CZ - Repubblica Ceca 3
EU - Europa 3
JM - Giamaica 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AZ - Azerbaigian 2
CH - Svizzera 2
CM - Camerun 2
DK - Danimarca 2
HN - Honduras 2
HR - Croazia 2
KZ - Kazakistan 2
LT - Lituania 2
LV - Lettonia 2
MA - Marocco 2
NP - Nepal 2
PL - Polonia 2
PT - Portogallo 2
PY - Paraguay 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AI - Anguilla 1
AU - Australia 1
CL - Cile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
IM - Isola di Man 1
JO - Giordania 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MG - Madagascar 1
MK - Macedonia 1
MY - Malesia 1
NI - Nicaragua 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
RS - Serbia 1
SC - Seychelles 1
SN - Senegal 1
TM - Turkmenistan 1
Totale 5.989
Città #
Southend 579
Dallas 360
Chandler 328
Singapore 244
Hong Kong 208
Jacksonville 157
Ann Arbor 151
Ashburn 140
Dublin 135
Woodbridge 133
Beijing 107
Verona 104
Houston 81
Munich 65
New York 59
Wilmington 47
Jinan 45
Lawrence 44
Princeton 44
Helsinki 41
Nanjing 41
Los Angeles 38
Shenyang 38
Redmond 34
Madrid 32
Tianjin 29
Brussels 28
The Dalles 28
Turku 28
Columbus 23
Sindelfingen 21
Buffalo 19
Milan 19
Redondo Beach 19
Seoul 19
Zhengzhou 19
Dearborn 17
Hebei 17
Ningbo 17
Guangzhou 16
Changsha 15
Haikou 15
Santa Clara 15
Hangzhou 14
Lancaster 14
San Francisco 14
Nanchang 13
Taizhou 13
Düsseldorf 12
Boardman 10
Jakarta 10
Redwood City 10
Seattle 10
São Paulo 10
Tokyo 10
Dong Ket 9
Florence 9
Jiaxing 9
Mexico City 9
Phoenix 9
Bologna 8
Brescia 8
Fairfield 8
Rome 8
Amsterdam 7
Lomé 7
Montreal 7
Chions 6
Moscow 6
Nuremberg 6
Taiyuan 6
Toronto 6
Washington 6
Augusta 5
Catania 5
Council Bluffs 5
Falls Church 5
Frankfurt am Main 5
Fuzhou 5
Hanoi 5
Ho Chi Minh City 5
Johannesburg 5
Kent 5
London 5
Rio de Janeiro 5
Baghdad 4
Bergamo 4
Chicago 4
Norwalk 4
Shanghai 4
Stockholm 4
Vienna 4
Belo Horizonte 3
Bishkek 3
Boston 3
Brooklyn 3
Cairo 3
Chennai 3
Erbil 3
Fossalunga 3
Totale 4.005
Nome #
A re-emerging marker for prognosis in hepatocellular carcinoma: the add-value of fishing c-myc gene for early relapse. 243
True 3q Chromosomal Amplification in Squamous Cell Lung Carcinoma by FISH and aCGH Molecular Analysis: Impact on Targeted Drugs 181
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutes 175
Genomic characterization of hepatoid tumors: context matters 171
LC3B and ph-S6K are both expressed in epithelioid and classic renal angiomyolipoma: a rationale tissue-based evidence for combining use of autophagic and mTOR targeted drugs 169
Cellular senescence markers p16INK4 and p21CIP1/WAF are predictors of Hodgkin's lymphoma outcome 162
ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung 161
Espressione di marcatori di migrazione e invasività nei foci fibroblastici nella fibrosi polmonare idiopatica 159
Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis 154
Linfoma splenico a "cellule della zona marginale": studio dell'espressione di TCL1 e t-bet 150
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification 148
The identification of a small but significant subset of patients still targetable with anti-HER2 inhibitors when affected by triple negative breast carcinoma 139
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma. 136
Cathepsin-k as a diagnostic marker in the identification of micro-granulomas in Crohn's disease 135
S100P expression in cholangiocarcinoma 134
Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Heat Shock Protein 90 Overexpression, Ki67 Proliferative Index, and Topoisomerase II-α Co-amplification as Predictors of Pathologic Complete Response to Neoadjuvant Chemotherapy With Trastuzumab and Docetaxel 133
Next-generation repeat-free FISH probes for DNA amplification in glioblastoma in vivo: Improving patient selection to MDM2-targeted inhibitors 127
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors. 126
Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma 126
The Local Complement Activation on Vascular Bed of Patients with Systemic Sclerosis: A Hypothesis-Generating Study 125
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 124
Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET/PTC rearrangements 123
Phospho-proteomic analysis of mantle cell lymphoma cells suggests a pro-survival role of B-cell receptor signaling. 118
Phospho-tyrosine profiling of mantle cell lymphoma cells suggests the BCR signalling pathway as a potential therapeutic target. 115
t(6;11) renal cell carcinoma: a study of seven cases including two with aggressive behavior, and utility of CD68 (PG-M1) in the differential diagnosis with pure epithelioid PEComa/epithelioid angiomyolipoma 114
CATHEPSIN-K IS A SENSITIVE IMMUNOHISTOCHEMICAL MARKER FOR DETECTION OF MICRO-GRANULOMAS IN HYPERSENSITIVITY PNEUMONITIS 112
Constitutive expression of DeltaN-p63alpha isoform in human thymus and thymic epithelial tumours 110
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma 110
MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathways 109
Phospho-tyrosine profiling of mantle cell lymphoma cells suggests the BCR signalling pathwayn as a potential therapeutic target 108
Epithelial to mesenchymal transition-related proteins ZEB1, β-catenin, and β-tubulin-III in idiopathic pulmonary fibrosis 107
HHV-8 and EBV are not commonly found in idiopathic pulmonary fibrosis 105
ANALISI DEL DNA MEDIANTE FLUORESCENT IN SITU HYBRIDIZATION (FISH) PER L’IDENTIFICAZIONE DI ERRORI DI SCAMBIO DI TESSUTI DOPO PROCEDURE CHIRURGICHE: APPLICAZIONI NELLA PRATICA CLINICA ED IMPLICAZIONI MEDICO LEGALI 101
Pulmonary Adenocarcinoma With Enteric Differentiation: Immunohistochemistry and Molecular Morphology 97
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets 95
Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumours display divergent genomic and transcriptomic profiles 90
TCL1 and CD11c expression in hairy-cell leukemia and their diagnostic role on bone marrow biopsies in the differential diagnosis with splenic marginal zone lymphoma 89
Parvalbumin immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney 89
pRB immunostaining in the differential diagnosis between pleomorphic xanthoastrocytoma and glioblastoma with giant cells 79
High performance of multiplex fluorescence in situ hybridization to simultaneous detection of BCL2 and BCL6 rearrangements: useful application in the characterization of DLBCLs 76
TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1 74
Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine 72
VEGFA amplification/increased gene copy number and VEGFA mRNA expression in renal cell carcinoma with TFEB gene alterations 70
The Immunohistochemical Loss of H3K27me3 in Intracranial Meningiomas Predicts Shorter Progression-Free Survival after Stereotactic Radiosurgery 70
TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms 69
Comparison of Primary and Metastatic Fumarate Hydratase-Deficient Renal Cell Carcinomas Documents Morphologic Divergence and Potential Diagnostic Pitfall With Peritoneal Mesothelioma 68
Endoscopic ultrasound fine-needle biopsy to assess DAXX/ATRX expression and alternative lengthening of telomeres status in non-functional pancreatic neuroendocrine tumors 65
Atypical meningiomas with an immunohistochemical profile consistent with hypermetabolic or proliferative molecular groups show high mitotic index, chromosomal instability, and higher recurrence risk 54
Neurotoxic effects of rotenone and deltamethrin prolonged exposure on adult zebrafish 53
MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC 52
STING is a prognostic factor related to tumor necrosis, sarcomatoid dedifferentiation, and distant metastasis in clear cell renal cell carcinoma 51
Stimulator of interferon genes (STING) immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney 49
Mucinous cystic neoplasms and simple mucinous cysts are two distinct precursors of pancreatic cancer: clinicopathological, genomic, and transcriptomic characterization 48
Glucagon-Producing Pancreatic Neuroendocrine Tumors (Glucagonomas) are Enriched in Aggressive Neoplasms with ARX and PDX1 Co-expression, DAXX/ATRX Mutations, and ALT (Alternative Lengthening of Telomeres) 43
Refining prognostic stratification of atypical meningiomas: significance of chromosome 1p deletion and brain invasion 37
mTOR eosinophilic renal cell carcinoma: a distinctive tumor characterized by mTOR mutation, loss of chromosome 1, cathepsin-K expression, and response to target therapy 30
Stimulator of interferon genes (STING) immunohistochemical expression in fumarate hydratase-deficient renal cell carcinoma: biological and potential predictive implications 29
SFPQ::TFE3-rearranged PEComa: Differences and analogies with renal cell carcinoma carrying the same translocation 22
Gene therapy device-based delivery of progranulin, prosaposin, and GDNF as a combined precision and neurorestorative therapy in the rat 6-OHDA model of parkinsonism 20
HER2-Driven Breast Cancer: Role of the Chaperonin HSP90 in Modulating Response to Trastuzumab-Based Therapeutic Combinations 18
Totale 6.119
Categoria #
all - tutte 22.801
article - articoli 19.301
book - libri 0
conference - conferenze 3.500
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.602


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021319 0 0 0 47 47 60 22 20 21 31 50 21
2021/2022501 49 125 26 58 30 18 12 33 16 16 30 88
2022/2023931 58 115 85 161 77 224 7 50 103 8 28 15
2023/2024513 24 37 40 59 76 102 16 23 4 34 83 15
2024/20251.349 58 72 85 193 52 47 60 43 227 88 167 257
2025/2026953 266 269 389 29 0 0 0 0 0 0 0 0
Totale 6.119